Cardiopulmonary Bypass in Cyanotic Patients. A Review of the Problems and Suggested Strategies

Similar documents
Going on Bypass. What happens before, during and after CPB. Perfusion Dept. Royal Children s Hospital Melbourne, Australia

MASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE

TRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006

How to maintain optimal perfusion during Cardiopulmonary By-pass. Herdono Poernomo, MD

Effective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature)

Surgical Management of TOF in Adults. Dr Flora Tsang Associate Consultant Department of Cardiothoracic Surgery Queen Mary Hospital

Intra-operative Effects of Cardiac Surgery Influence on Post-operative care. Richard A Perryman

ECMO vs. CPB for Intraoperative Support: How do you Choose?

TRANSFUSION SUPPORT IN HEPATOBILIARY AND PANCREATIC SURGERIES

Transfusion Requirements and Management in Trauma RACHEL JACK

Use of Blood Lactate Measurements in the Critical Care Setting

Blood Management of the Cardiac Patient in the Postoperative Period

Blood Transfusion Guidelines in Clinical Practice

Navigating the Dichotomies Between Literature and Your Clinical Practice

Recent experimental studies have documented that 1

Crossmatching and Issuing Blood Components; Indications and Effects.

Risk Factor Evaluation for Thrombosis and Bleeding in Pediatric Patients with Heart Disease

OPCABG for Full Myocardial Revascularisation How we do it

Chapter 3 MAKING THE DECISION TO TRANSFUSE

Cardiac anaesthesia. Simon May

University of Bristol - Explore Bristol Research

Conventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury?

Coagulation an Overview Dr.Abdolreza Abdolr Afrasiabi Thal assem a & Heamophili hilia G ene i tic R esearc C en er Shiraz Medical Medic University

John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne

10/10/2018. Disclosures. Introduction (II) Introduction (I) The authors have no disclosures

Management of Cardiogenic Shock. Dr Stephen Pettit, Consultant Cardiologist

MANAGEMENT OF COAGULOPATHY AFTER TRAUMA OR MAJOR SURGERY

Coagulative Necrosis of Myocardium. Dr Rodney Itaki Division of Pathology

12/1/2009. Chapter 19: Hemorrhage. Hemorrhage and Shock Occurs when there is a disruption or leak in the vascular system Internal hemorrhage

CCAS CPB Workshop Curriculum Outline Perfusion: What you might not know

HYPOVOLEMIA AND HEMORRHAGE UPDATE ON VOLUME RESUSCITATION HEMORRHAGE AND HYPOVOLEMIA DISTRIBUTION OF BODY FLUIDS 11/7/2015

Razvana Akbar Anticoagulation Pharmacist LTH

Blood is serious business

Introduction to coagulation and laboratory tests

Case scenario V AV ECMO. Dr Pranay Oza

The Anatomy and Physiology of the Circulatory System

Blood Transfusion and Heart Surgery at Alder Hey. Philip Arnold, Consultant Paediatric Cardiac Anaesthetist, Alder Hey Children s Hospital, Liverpool

LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA Transfusion Criteria Version#2 POLICY NO.

My Bloody Talk. Dr Ben Turner MBBS, FANZCA, FCICM The Royal Children s Hospital, Melbourne

WHITE PAPERS PRESENTATION VIDEO DOCUMENTATION EXPERIMENT WO NDCLOT. The WoundClot Principals for Effective Bleeding Control PRESENTATION

Difficult Scenarios for Myocardial Protection SAHA Gil Bolotin M.D., Ph.D. Rambam Medical Center, Haifa, Israel

Perioperative Management of TAPVC

Cerebral Complication after Open Heart Surgery

Steph ani eph ani Mi M ck i MD Cleveland Clinic

Razvana Akbar Anticoagulation Pharmacist LTH

The principle of 1:1:1 blood product use in the resuscitation of trauma victims. K. D. Boffard

A Guide To Safe Blood Transfusion Practice

Role of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University

Intraoperative application of Cytosorb in cardiac surgery

Blood products and plasma substitutes

UNIT VI. Chapter 37: Platelets Hemostasis and Blood Coagulation Presented by Dr. Diksha Yadav. Copyright 2011 by Saunders, an imprint of Elsevier Inc.

Lung Cancer Resection on Cardiopulmonary Bypass. Daniel J. Boffa, MD Yale University

Hemostasis Haemostasis means prevention of blood loss from blood vessels.

Blood and blood component therapy in the critically ill patient

Active date July Ratification date: Review date January 2014 Applies to: Staff managing patients on warfarin. Exclusions:

KASHVET VETERINARIAN RESOURCES FLUID THERAPY AND SELECTION OF FLUIDS

Survival Rates of Children with Congenital Heart Disease continue to improve.

GUIDELINES FOR MANAGEMENT OF BLEEDING AND EXCESSIVE ANTICOAGULATION WITH ORAL ANTICOAGULANTS

DEMYSTIFYING VADs. Nicolle Choquette RN MN Athabasca University

TRAUMA RESUSCITATION. Dr. Carlos Palisi Dr. Nicholas Smith Liverpool Hospital

Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban

Cardiovascular System. Supplementary Information

Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine

Supplementary table to Bennett et al. Peripheral arterial disease and Virchow s triad (Thromb Haemost 2009; 101.6)

TOBY. Daily log. Data Collection Booklet. This form should be completed from the time the baby is randomised until 80 hours after randomisation

No Disclosures. Objectives. Objectives 10/10/2018

DISCUSSION QUESTIONS: BLOOD AND TRANSPORT IN ANIMALS

University of Groningen. Impaired Organ Perfusion Morariu, Aurora

Human Cardiovascular Physiology: Blood Pressure and Pulse Determinations

Radboud University Nijmegen Medical Centre Why measure cardiac output in critically ill children?

Major Haemorrhage Protocol. Commentary

GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS

Haematology and Transfusion

Emergency surgery in acute coronary syndrome

Guslihan Dasa Tjipta Division of Perinatology Department of Child Health Medical School University of Sumatera Utara

COAGULATION, BLEEDING, AND TRANSFUSION IN URGENT AND EMERGENCY CORONARY SURGERY

the bleeding won t stop? Liane Manz RN, BScN, CNCC(c) Royal Alexandra Hospital

Thromboembolismand Shock 血管栓塞和休克

Recombinant Activated Factor VII: Useful. Department of Surgery Grand Rounds 11/8/10 David Mauchley MD

Anatomy and Physiology

Appendix 3 PCC Warfarin Reversal

Coagulation, Haemostasis and interpretation of Coagulation tests

Differences In Efficacy Of Antiplatelet Therapy-Is That Gender Specific?

Primary Exam Physiology lecture 5. Haemostasis

Hemostasis Haemostasis means prevention of blood loss from blood vessels.

ECMO Primer A View to the Future

Blood transfusion. Dr. J. Potgieter Dept. of Haematology NHLS - TAD

Extra Corporeal Life Support for Acute Heart failure

Hypothermia in Neonates with HIE TARA JENDZIO, DNP(C), RN, RNC-NIC

Prothrombin Complex Concentrate- Octaplex. Octaplex

Guidelines for Use of Canine Blood Components

BLEEDING AND USE OF BLOOD PRODUCTS AFTER HEART OPERATIONS IN INFANTS

Platelet-fibrin clot. 50Kd STEMI. Abciximab. Video of a IIb/IIIa inhibitor in action. Unstable Angina and non-stsegment

Y. Helen Zhang, MD Andy Nguyen, MD 10/28/2012

Transfusion Pitfalls. Objectives. Packed Red Blood Cells. TRICC trial (subgroups): Is transfusion always good? Components

Thinking outside of the box Perfusion management and myocardial protection strategy for a patient with sickle cell disease

Pretransfusion Testing

Dr Shikha Chattree Haematology Consultant Sunderland Royal infirmary

Heinz-Hermann Weitkemper, EBCP. 4th Joint Scandinavian Conference in Cardiothoracic Surgery 2012 Vilnius / Lithuania

OPCAB IS NOT BETTER THAN CONVENTIONAL CABG

Transcription:

Cardiopulmonary Bypass in Cyanotic Patients A Review of the Problems and Suggested Strategies

Extra-ordinary Problems Encountered During C.P.B. for Cyanotic Heart Disease 1. Extra Dilutional Requirements 2. Predisposition to Post-operative Bleeding 3. Numbers of Collateral Vessels 4. Re-oxygenation Injury 5. Others

1. Dilution Viscosity Shear rates Perfusion Blood requirements in priming

1. Dilution Generally: 20-40% or 20-40ml/kg. Cyanotic patients require greater dilution in order to: viscosity shear rates perfusion R.C.H. 98

1. Dilution in cyanotic patients... Oxygen Carrying Capacity Leucocyte & Platelet Numbers Coagulation Proteins Plasma Oncotic Pressure Diuresis

Turner-Gomes S.O., Williams W.G., et al J. Thor. C.V. Surg. 107 (2), 1994 Thrombin Regulation & Activity Cyanotic Patients - Higher Risk of Haemorrhage - Dilutional in Origin R.C.H. 98

Milam, J.D., Cooley, D.A., et al J. Thor. C.V. Surg. 89 (4), 1985 111 Patients Group 1: Non-cyanotic Normal Dilution Hb<10 Group 2: Cyanotic Normal Dilution Hb>10 Group 3: Cyanotic Dilution To Below 10gm% Hb<10

MILAM et al. - Results R.C.H. 98 At 24 Hrs Grp3 Hct > Grp 1 ( Diuresis) Grp 3 Platelets Only To 106,000 Grp 3 Fibrinogen, Factors X, Ix, Vii, V, Ii All And Grp 3 Aptt & Pt Prolonged But Grp 3 Bld. Loss 45% Less Than Grp 2 And Grp 3 Bld. & Bld. Product Usage 54% Less Than Grp 2 Grp 3 Re-op (Bleeding) 14% Grp 2 Re-op (Bleeding) 40%

MILAM et al. - Findings Haemodilution Is A Must Suggests Albumin Or F.F.P.

2. Post - Operative Bleeding In Cyanotic Patients... erythrocyte number plasma volume & clotting factors leucocytes, platelets hepatic congestion (secondary to c.h.d.) production of clotting factors

2. Post - Operative Bleeding In Cyanotic Patients... Clot Retraction? Hypo-fibrinogenaemia Platelet Aggregation Inverse Relationship? Cause Implicated In Low Grade D.I.C. R.C.H. 98

2. Post - Operative Bleeding In Cyanotic Patients... Rinder et. al. (J.Thorac.Card.Vasc.Surg. 107[1],1994) Found Cyanotic Patients - Baseline GP Ib Receptor Deficit

2. Post Operative Bleeding Whilst On C.P.B.... Dilution of platelets, clotting factors Cardiotomy suction C.P.B. Itself Platelet damage/dysfunction Thromboxane & ADP release Platelet dysfunction Protein damage

2. Post Operative Bleeding Zonis et al. (J.Thorac.Card.Vasc.Surg. 111[5],1996) Preoperative transexamic acid Significant reduction in post-op blood loss and blood product requirements.

3. Increased Collateral Return Cyanosis Often Means... Blood in l.a. Systemic flow? pump output Visibility in operative field? pump output R.C.H. 98

3. Increased Collateral Flow Cross-clamp times Cardiotomy suction Rewarming of myocardium

4. Re-oxygenation Injury Buckberg Group Eur. J. Card. Thor. Surg 9(8), 1995 J. Clin. Invest. 93(6), 1994 Rapid in oxygenation of hypoxic tissue Cytotoxics (No, OFRS, PO-NO 3 ) Negates effects of beneficial CPS CPB in hypoxaemic pts. MUST be instigated using lowest po 2

5. Cyanosis - Other Considerations Wong, P.C., Jonas, R.A., et al. Circulation. 86(5) (Supp II), 1992 Choreoathetosis & CPB Found: Higher incidence in cyanotic patients with systemic to pulmonary collaterals

5. Cyanosis - Other Considerations Silverman, N.A., Kohler, J., et al. Ann. Thor. Surg. 37(4), 1984 Cyanotic dog model Found: global ventricular function ATP stores Suggests cyanotic patients at higher risk? Special CPS needed (cf Buckberg)

5. Cyanosis - Other Considerations del Nido, P.J., Trusler, G.A., et al. J. Thor. C.V. Surg. 95(2), 1988 Cyanotic Grp Non-cyanotic Grp Mean Age 6.3 yrs 54 yrs Haemoglobin 15.5 gm/dl 11.0 gm/dl X-Clamp Time 41 min 70 min Pre-Clamp ATP 24 mmol/kg dry wt. 16 mmol/kg/ dry wt Myocardial Temp 12.5 deg C 16.9 deg C R.C.H. 98

del Nido et al. - Results After Similar Myocardial Protection ATP Levels Lactate levels Histopathology In Cyanotic Group Focal myocyte necrosis Presence of contraction bands

del Nido et al. Suggests: Cyanotic patients are more susceptible to ischaemic insult and to reperfusion injury May have a defect in oxidative metabolism? Improved cps needed (cf Buckberg)

Summary Dilute adequately Maintain protein levels on C.P.B Cooling Prepare for post-operative bleeding Introduce CPB appropriately? Research into appropriate protocols for cyanotic patients

Antioxidant supplimentation of the CPB prime avoids unintended reoxygenation injury and results in improved biochemical and functional status. Ihnken K. Buckberg GD. et al Cardiovascular Surgery. 5(6):608-19, 1997